Corbus Pharmaceuticals Holdings, Inc. Lease, Cost
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Lease, Cost of $1.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-09
- Corbus Pharmaceuticals Holdings, Inc. lease, cost for fiscal 2025 was $1.24M, a 0.00% change from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. lease, cost for fiscal 2024 was $1.24M, a 0.00% change from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. lease, cost for fiscal 2023 was $1.24M, a 0.04% decline from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. lease, cost for fiscal 2022 was $1.24M, a 0.00% change from fiscal 2021.
| Period end | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.24M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $1.24M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $1.24M 10-K · filed 2025-03-11 | $1.24M 10-K · filed 2024-03-12 |
| 2022-12-31 | $1.24M 10-K · filed 2024-03-12 | |
| 2021-12-31 | $1.24M 10-K · filed 2023-03-07 | |
| 2020-12-31 | $1.24M 10-K · filed 2022-03-08 | |
| 2019-12-31 | $1.03M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |